Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Category: News

News

Dr. Zanos was invited to discuss groundbreaking ketamine clinical trial on Cyprus Broadcasting Corporation

No Comments
| News

We are pleased to announce that Dr. Zanos was recently invited to appear on the Cyprus Broadcasting Corporation (RIK) to discuss our laboratory’s groundbreaking clinical trial investigating ketamine as a treatment for opioid use disorder (OUD). This pioneering study—the first of its kind in Cyprus—is being conducted at the “GEFYRA” (BRIDGE) Substitute Substance Unit in […]

Read More »

New special issue led by our lab: Climate-Driven Effects on the Human Microbiome and Public Health

No Comments
| News

We’re excited to announce that our laboratory is leading a special issue in Microorganisms journal focusing on the intersection of climate change and the human microbiome. Dr. Zanos and Dr. Onisiforou are serving as Guest Editors for this initiative. Our special issue aims to explore how environmental changes affect human-associated microbial communities and their subsequent […]

Read More »

The Zanos Lab welcomes our new Marie Skłodowska-Curie (Onisilos co-fund) fellow, Dr. Polymnia Louka!

No Comments
| News

We are excited to welcome Dr. Polymnia Louka to the Translational Neuropharmacology Lab as an ONISILOS Marie Skłodowska-Curie Fellow. Her research focuses on the effects of ketamine’s enantiomers and active metabolites on depression-induced bone impairment, aiming to uncover novel therapeutic interventions at the intersection of neuropharmacology, bone biology, and imaging. Dr. Louka has a diverse […]

Read More »

Cover story feature: Zanos Lab’s groundbreaking paper on microbial influences in Alzheimer’s Disease

No Comments
| News

We are delighted to announce that our recent publication on microbial influences in Alzheimer’s disease has been selected for the cover story for Volume 13, Issue 1 (January 2025) of Microorganisms journal. This recognition by the journal highlights the significance and timeliness of our research in challenging traditional paradigms of Alzheimer’s Disease treatment. The cover […]

Read More »

Public lecture on stress and mental health coordinated by Dr. Zanos

No Comments
| News

Dr. Panos Zanos coordinated a public lecture on stress and mental health on January 23rd at the Salaminio Free/Open University of Famagusta. The event featured presentations by Dr. Maria Tsiarli, Ph.D. in Developmental Neurobiology, on “Stress and Nervous System Health,” and Professor Georgia Panayiotou, Dean of the Graduate School at the University of Cyprus, on […]

Read More »

Our postdoctoral fellow, Dr. Andria Michael, awarded a YUFE4Postdocs fellowship with €167,880 in funding

No Comments
| News

We are excited to announce that Dr. Andria Michael, a postdoctoral fellow in the Zanos Lab, has been awarded the highly competitive YUFE4Postdocs Fellowship, co-funded by the European Union’s Marie Skłodowska-Curie Actions (MSCA) program. This fellowship provides Dr. Michael with a 26-month research position at the University of Cyprus, offering exceptional training opportunities and a […]

Read More »

New Publication from the Zanos Lab led by Dr. Anna Onisiforou: Microbial Influences in Alzheimer’s Disease

No Comments
| News

For decades, Alzheimer’s disease (AD) research has been dominated by the amyloid cascade hypothesis, which positions amyloid-beta (Aβ) accumulation as the primary driver of the disease. However, the consistent failure of Aβ-targeted therapies to demonstrate efficacy, coupled with significant safety concerns, has underscored the critical need to rethink our approach to AD treatment. In our […]

Read More »

Zanos Laboratory secures major grant funding of €600,000

No Comments
| News

We are delighted to announce that the Zanos Laboratory has secured €600,000 in research funding by the Research and Innovation Foundation, to support several innovative research programs in neuroscience and mental health. This funding will enable our laboratory to pursue multiple distinct lines of investigation that address important questions in mental health research. In collaboration […]

Read More »

Dr. Zanos presents groundbreaking research on novel therapeutic approaches for opioid addiction

No Comments
| News

We are pleased to announce that Dr. Zanos recently delivered an impactful presentation on innovative approaches to treating opioid addiction. The lecture highlighted cutting-edge research developments and provided insights into the PROUD study, a pioneering clinical trial investigating ketamine’s potential in preventing opioid relapse. During this enlightening session, Dr. Zanos shared important findings about the […]

Read More »

The Translational Neuropharmacology (Zanos) Lab participates at the Center for Applied Neuroscience 2024 Conference

No Comments
| News

We are excited to share that Dr. Zanos, Director of the Translational Neuropharmacology Lab, delivered an engaging talk at the 14th Annual Scientific Conference of the Center for Applied Neuroscience (CAN), held at the University of Cyprus. His presentation, titled “From Whiskers to Wisdom: How Rodent Models can Reveal Neural Mechanisms Underlying Decision-Making and Cognitive […]

Read More »

Posts pagination

Previous 1 … 6 7 8 … 13 Next

Recent Posts

  • Dr. Charalambous presents brain aging research at AAIC 2026 July 13, 2026
  • Dr. Panoutsopoulos presents research on ketamine and early neurodevelopment at FENS Forum 2026 July 8, 2026
  • Research spotlight: Unraveling the role of Eukaryotic Elongation Factor 2 Kinase in the antidepressant mechanism of (2R,6R)-hydroxynorketamine June 4, 2026
  • Research spotlight: Alexithymia and emotion regulation across smoking status groups May 26, 2026
  • New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease? March 12, 2026

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress